The 25 references in paper N. Kashirskaya Yu., E. Amelina L., S. Krasovskiy A., Н. Каширская Ю., Е. Амелина Л., С. Красовский А. (2017) “Ранняя эрадикация синегнойной инфекции при муковисцидозе // Early eradication of Pseudomonas aeruginosa infection in cystic fibrosis” / spz:neicon:pulmonology:y:2017:i:1:p:81-86

1
Шагинян И.А., Капранов Н.И., Чернуха М.Ю. и др. Микробный пейзаж нижних дыхательных путей у различных возрастных групп детей, больных муковисцидозом. Журнал микробиологии, эпидемиологии и имму( нобиологии.2009; 1: 15–20.
(check this in PDF content)
2
Красовский С.А., Амелина Е.Л., Кондратьева Е.И. и др. Респираторная инфекция нижних дыхательных путей у больных муковисцидозом в Российской Федерации по данным Национального регистра (2014). Пульмонология. 2016; 28 (4): 421–435. DOI: 10.18093/ 0869-0189-2016-26-4-421-435.
(check this in PDF content)
3
Flume P.A., VanDevanter D.R. Clinical applications of pulmonary delivery of antibiotics.Adv. Drug Deliv. Rev.2015; 85: 1–6. DOI: 10.1016/j.addr.2014.10.009.
(check this in PDF content)
4
Smyth A.R., Bell S.C., Bojcin S. et al. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. J. Cyst. Fibros. 2014; 13 (Suppl. 1): S23–S42. DOI: 10.1016/j.jcf.2014.03.010.
(check this in PDF content)
5
Høiby N., Frederiksen B., Pressler T. Eradication of early Pseudomonas aeruginosa infection. J. Cyst. Fibros.2005; 4 (Suppl. 2): 49–54. DOI: 10.1016/j.jcf.2005.05.018.
(check this in PDF content)
6
Taccetti G., Bianchini E., Cariani L. et al. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomized multicentre study comparing two different protocols. Thorax. 2012; 67 (10): 853–859. DOI: 10.1136/thoraxjnl-2011-200832.
(check this in PDF content)
7
Lee T.W. Eradication of early Pseudomonas infection in cystic fibrosis. Chron. Respir. Dis.2009; 6 (2): 99–107. DOI: 10.1177/1479972309104661.
(check this in PDF content)
8
Emerson J., Rosenfeld M., McNamara S. et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr. Pulmonol.2002; 34 (2): 91–100. DOI: 10.1002/ppul.10127.
(check this in PDF content)
9
Langton-Hewer S.C., Smyth A.R. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst. Rev.2014; (11): CD004197. DOI: 10.1002/14651858.CD004197.pub4.
(check this in PDF content)
10
Munck A., Bonacorsi S., Mariani-Kurkdjian P. et al. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization.Pediatr. Pulmonol.2001; 32 (4): 288–292. DOI: 10.1002/ppul.1121.
(check this in PDF content)
11
Frederiksen B., Koch C., Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.Pediatr. Pulmonol.1997; 23 (5): 330–335.
(check this in PDF content)
12
Ratjen F., Comes G., Paul K. et al. Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis. Pediatr. Pulmonol. 2001; 31 (1): 13–16.
(check this in PDF content)
13
Ratjen F., Munck A., Kho P., Angyalosi G. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax. 2010; 65 (4): 286–291. DOI: 10.1136/thx.2009.121657.
(check this in PDF content)
14
Treggiari M.M., Retsch-Bogart G., Mayer-Hamblett N. Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection inchildren with cystic fibrosis. Arch. Pediatr. Adolesc. Med.2011; 165 (9): 847–856.
(check this in PDF content)
15
Valerius N.H., Koch C., Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet. 1991; 338 (8769): 725–726.
(check this in PDF content)
16
Antibiotic Treatment for Cystic Fibrosis. Report of the UK Cystic Fibrosis Trust Antibiotic Working Group. London: UK Cystic Fibrosis Trust; 2009.
(check this in PDF content)
17
Smith A.L., Fiel S.B., Mayer-Hamblett N. et al. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest. 2003; 123 (5): 1495–1502.
(check this in PDF content)
18
Kenny S.L., Shaw T.D., Downey D.G. et al. Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis. BMJ Open Respir. Res.2014; 1: e000021. DOI: 10.1136/bmjresp2014-000021.
(check this in PDF content)
19
Амелина Е.Л., Ашерова И.К., Волков И.К. и др. Проект Национального консенсуса Муковисцидоз: определение, диагностические критерии, терапия. Раздел Антимикробная терапия. Педиатрия. 2014; 93 (4): 107–124.
(check this in PDF content)
20
Brodt A.M., Stovold E., Zhang L. Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review. Eur. Respir. J.2014; 44 (2): 382–393. DOI: 10.1183/09031936.00018414.
(check this in PDF content)
21
Rosenfeld M., Emerson J., McNamara S. et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J. Cyst. Fibros.2012; 11 (5): 446–453. DOI: 10.1016/j.jcf.2012.04.003.
(check this in PDF content)
22
Proesmans M., Vermeulen F., Boulanger L. et al. Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis.J. Cyst. Fibros.2013; 12 (1): 29–34. DOI: 10.1016/j.jcf.2012.06.001.
(check this in PDF content)
23
Geller D.E., Flume P.A., Staab D. et al. Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med.2011; 183 (11): 1510–1516. DOI: 10.1164/rccm. 201008-1293OC.
(check this in PDF content)
24
Stanojevic S., Waters V., Mathew J.L. et al. Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis.J. Cyst. Fibros.2014; 13 (2): 172–178. DOI: 10.1016/j.jcf.2013.09.002.
(check this in PDF content)
25
Cohen-Cymberknoh M., Gilead N., Gartner S. et al. Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis. J. Cyst. Fibros.2016; 15 (6): 776–782. DOI: 10.1016/j.jcf.2016.04.006. Поступила 16.02.17
(check this in PDF content)